SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000918066-04-000075
Filing Date
2004-05-07
Accepted
2004-05-07 19:21:44
Documents
1
Period of Report
2004-05-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT c0001206369d20040507f4af.html 4/A  
1 PRIMARY DOCUMENT c0001206369d20040507f4af.xml 4/A 10322
  Complete submission text file 0000918066-04-000075.txt   12150
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Issuer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GENAISSANCE PHARMACEUTICALS INC FIVE SCIENCE PARK NEW HAVEN CT 06511
Business Address C/O GENAISSANCE PHARMACEUTICALS INC FIVE SCIENCE PARK NEW HAVEN CT 06511 2037731450
KLEIN JOSEPH III (Reporting) CIK: 0001206369 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-23736 | Film No.: 04790693